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Objective/Background: Interferon (IFN)-c-release assays (IGRAs) are designed for the diagno-
sis of tuberculosis (TB) infection. The new IGRA called QuantiFERON-TB Plus (QFT-Plus) is
based on enzyme-linked immunosorbent assay (ELISA) detection of IFN-c following
Myobacterium tuberculosis-antigen stimulation with TB1 and TB2 antigens. TB1 elicits a
cell-mediated immune response by CD4 T cells and TB2 elicits a response from both CD4
and CD8 T cells. Here, we characterized variations IFN-c release detected by ELISA to
QFT-IT and QFT-Plus in patients with active TB and latent TB infection (LTBI) at baseline
and during or after specific treatment (follow-up).
Methods: We studied seven patients with active TB and 10 patients with LTBI at baseline
and during treatment either for active disease or preventive therapy. IFN-c release detected
by ELISA to QFT-IT and QFT-Plus was concomitantly evaluated over time. Statistical analy-
sis was performed using a nonparametrical test for a paired dataset (Wilcoxon test).
Results: All participants responded to the mitogen, with all active-TB patients responding
to QFT-IT or QFT-Plus at baseline. The responses did not change over time either qualita-
tively (number of responders) or quantitatively (IFN-c release evaluated as IU/mL). Among
the LTBI group, although all participants responded to both QFT-IT and QFT-Plus and the
responses did not change over time, the quantitative responses to QFT-Plus showed a dif-
ferent trend. Specifically, response to TB2 was significantly lower at follow-up as compared
with that observed at baseline (p = 0.004), whereas the response to TB1 was not signifi-
cantly different (p = 0.16).pallanzani, Padiglione Del Vecchio, Via Portuense 292 00149 Rome, Italy.
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ijmyco.2016.09.029Conclusion: To our knowledge, this is the first report characterizing IFN-c responses to
QFT-Plus antigens in participants with active TB and LTBI over time. The data need to be
confirmed in larger settings; however, we showed that monitoring IFN-c release in response
to TB2 can be used to evaluate preventive therapy immune changes. This can be useful also
as a tool for public health control strategies in settings where preventive treatment is
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